Peiyi Xia
Jian She Dong Road 1
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CD27 expression is a clinically accessible biomarker for predicting immunotherapy response in melanoma.
Journal: NPJ precision oncology
Published: June 09, 2025
BTLA promoter hypomethylation correlates with enhanced immune cell infiltration, favorable prognosis, and immunotherapy response in melanoma.
Journal: Journal for immunotherapy of cancer
Published: February 17, 2025
Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients.
Journal: Frontiers in oncology
Published: November 01, 2022
Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers.
Journal: Journal of translational medicine
Published: February 24, 2021
Gefitinib Combined with Cetuximab for the Treatment of Lung Adenocarcinoma Harboring the EGFR-Intergenic Region (SEC61G) Fusion and EGFR Amplification.
Journal: The oncologist
Published: February 07, 2021
PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1.
Journal: Neoplasia (New York, N.Y.)
Published: January 12, 2021
Implication of Microsatellite Instability in Chinese Cohort of Human Cancers.
Journal: Cancer management and research
Published: July 29, 2020
A Case of Primary Resistance to Gefitinib due to Novel Deletion-Insertion Mutation of EGFR Exon 19 in NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 14, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026